Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,236 | 103,139 | 91,681 | 105,730 | 76,418 |
| Marketable Securities | 2,029 | N/A | N/A | N/A | N/A |
| Receivables | 48,054 | 57,446 | 24,855 | 18,817 | 44,200 |
| Inventories | 12,722 | 13,521 | 18,325 | 16,897 | 24,721 |
| Income taxes - deferred | 2,638 | 1,870 | N/A | N/A | 295 |
| Other current assets | 0 | 10,000 | 10,000 | 0 | 0 |
| TOTAL | $243,493 | $193,814 | $152,887 | $144,310 | $147,337 |
| Non-Current Assets | |||||
| PPE Net | 152,701 | 131,834 | 124,656 | 110,218 | 78,174 |
| Intangibles | 5,029 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 99,096 | 19,041 | 13,245 | 18,980 | 12,744 |
| TOTAL | $256,826 | $150,875 | $137,901 | $129,198 | $90,918 |
| Total Assets | $500,319 | $344,689 | $290,788 | $273,508 | $238,255 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,187 | 5,791 | 6,248 | 3,514 | 2,456 |
| Accounts payable and accrued liabilities | 25,409 | 17,159 | 18,254 | 20,257 | 27,366 |
| Accrued Expenses | 25,284 | 16,496 | 12,779 | 11,280 | 10,460 |
| TOTAL | $75,719 | $54,701 | $54,021 | $55,661 | $64,347 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,239 | 44,927 | 35,935 | 42,588 | 31,368 |
| Deferred Revenues | 7,839 | 255 | 232 | 902 | 1,432 |
| Other Non-Current Liabilities | 20,928 | 5,845 | 2,207 | 1,627 | 1,071 |
| TOTAL | $51,039 | $46,173 | $37,418 | $46,688 | $35,436 |
| Total Liabilities | $126,758 | $100,874 | $91,439 | $102,349 | $99,783 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,128 | 30,859 | 30,172 | 29,750 | N/A |
| Common Shares | 35 | 31 | 30 | 30 | 28 |
| Retained earnings | 173,850 | 122,152 | 91,008 | 70,326 | 47,997 |
| Other shareholders' equity | 1,987 | 1,140 | -859 | -1,130 | -473 |
| TOTAL | $373,561 | $243,815 | $199,349 | $171,159 | $138,472 |
| Total Liabilities And Equity | $500,319 | $344,689 | $290,788 | $273,508 | $238,255 |